Dataset Information

Novel mutant mouse line emphasizes the importance of protein kinase C theta for CD4⁺ T lymphocyte activation.

ABSTRACT:

Background

The protein kinase C theta (PKC?) has an important and non-redundant function downstream of the antigen receptor and co-receptor complex in T lymphocytes. PKC? is not only essential for activation of NF-?B, AP-1 and NFAT and subsequent interleukin-2 expression, but also critical for positive selection and development of regulatory T lymphocytes in the thymus. Several domains regulate its activity, such as a pseudosubstrate sequence mediating an auto-inhibitory intramolecular interaction, the tandem C1 domains binding diacylglycerol, and phosphorylation at conserved tyrosine, threonine as well as serine residues throughout the whole length of the protein. To address the importance of the variable domain V1 at the very N-terminus, which is encoded by exon 2, a mutated version of PKC? was analyzed for its ability to stimulate T lymphocyte activation.

Methods

T cell responses were analyzed with promoter luciferase reporter assays in Jurkat T cells transfected with PKC? expression constructs. A mouse line expressing mutated instead of wild type PKC? was analyzed in comparison to PKC?-deficient and wild type mice for thymic development and T cell subsets by flow cytometry and T cell activation by quantitative RT-PCR, luminex analysis and flow cytometry.

Results

In cell lines, the exon 2-replacing mutation impaired the transactivation of interleukin-2 expression by constitutively active mutant form of PKC?. Moreover, analysis of a newly generated exon 2-mutant mouse line (PKC?-E2^mut) revealed that the N-terminal replacement mutation results in an hypomorph mutant of PKC? combined with reduced PKC? protein levels in CD4⁺ T lymphocytes. Thus, PKC?-dependent functions in T lymphocytes were affected resulting in impaired thymic development of single positive T lymphocytes in vivo. In particular, there was diminished generation of regulatory T lymphocytes. Furthermore, early activation responses such as interleukin-2 expression of CD4⁺ T lymphocytes were significantly reduced even though cell viability was not affected. Thus, PKC?-E2^mut mice show a phenotype similar to conventional PKC?-deficient mice.

Conclusion

Taken together, PKC?-E2^mut mice show a phenotype similar to conventional PKC?-deficient mice. Both our in vitro T cell culture experiments and ex vivo analyses of a PKC?-E2-mutant mouse line independently validate the importance of PKC? downstream of the antigen-receptor complex for activation of CD4⁺ T lymphocytes.

SUBMITTER: Siegmund K

PROVIDER: S-EPMC6537413 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Novel mutant mouse line emphasizes the importance of protein kinase C theta for CD4<sup>+</sup> T lymphocyte activation.

Siegmund Kerstin K Thuille Nikolaus N Posch Nina N Fresser Friedrich F Leitges Michael M Baier Gottfried G

Cell communication and signaling : CCS 20190528 1

<h4>Background</h4>The protein kinase C theta (PKCθ) has an important and non-redundant function downstream of the antigen receptor and co-receptor complex in T lymphocytes. PKCθ is not only essential for activation of NF-κB, AP-1 and NFAT and subsequent interleukin-2 expression, but also critical for positive selection and development of regulatory T lymphocytes in the thymus. Several domains regulate its activity, such as a pseudosubstrate sequence mediating an auto-inhibitory intramolecular i ...[more]

PMID: 31138259

Similar Datasets

Project description:The majority of the clinico-pathological variability observed in patients harboring a repeat expansion in the C9orf72-SMCR8 complex subunit (C9orf72) remains unexplained. This expansion, which represents the most common genetic cause of frontotemporal lobar degeneration (FTLD) and motor neuron disease (MND), results in a loss of C9orf72 expression and the generation of RNA foci and dipeptide repeat (DPR) proteins. The C9orf72 protein itself plays a role in vesicular transport, serving as a guanine nucleotide exchange factor that regulates GTPases. To further elucidate the mechanisms underlying C9orf72-related diseases and to identify potential disease modifiers, we performed an extensive RNA sequencing study. We included individuals for whom frontal cortex tissue was available: FTLD and FTLD/MND patients with (n?=?34) or without (n?=?44) an expanded C9orf72 repeat as well as control subjects (n?=?24). In total, 6706 genes were differentially expressed between these groups (false discovery rate [FDR]?<?0.05). The top gene was C9orf72 (FDR?=?1.41E-14), which was roughly two-fold lower in C9orf72 expansion carriers than in (disease) controls. Co-expression analysis revealed groups of correlated genes (modules) that were enriched for processes such as protein folding, RNA splicing, synaptic signaling, metabolism, and Golgi vesicle transport. Within our cohort of C9orf72 expansion carriers, machine learning uncovered interesting candidates associated with clinico-pathological features, including age at onset (vascular endothelial growth factor A [VEGFA]), C9orf72 expansion size (cyclin dependent kinase like 1 [CDKL1]), DPR protein levels (eukaryotic elongation factor 2 kinase [EEF2K]), and survival after onset (small G protein signaling modulator 3 [SGSM3]). Given the fact that we detected a module involved in vesicular transport in addition to a GTPase activator (SGSM3) as a potential modifier, our findings seem to suggest that the presence of a C9orf72 repeat expansion might hamper vesicular transport and that genes affecting this process may modify the phenotype of C9orf72-linked diseases.